daclatasvir
E1242136
UNEXPLORED
Daclatasvir is a direct-acting antiviral medication used to treat chronic hepatitis C virus infection, typically as part of combination therapy.
All labels observed (1)
| Label | Occurrences |
|---|---|
| daclatasvir canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T16946207 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: daclatasvir Context triple: [Sovaldi, usedInCombinationWith, daclatasvir]
-
A.
Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
-
B.
Harvoni
Harvoni is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection.
-
C.
Sovaldi
Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
-
D.
Waylivra
Waylivra is a prescription antisense oligonucleotide therapy used to treat familial chylomicronemia syndrome (FCS) by reducing triglyceride levels in the blood.
-
E.
velpatasvir
Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: daclatasvir Target entity description: Daclatasvir is a direct-acting antiviral medication used to treat chronic hepatitis C virus infection, typically as part of combination therapy.
-
A.
Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
-
B.
Harvoni
Harvoni is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection.
-
C.
Sovaldi
Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
-
D.
Waylivra
Waylivra is a prescription antisense oligonucleotide therapy used to treat familial chylomicronemia syndrome (FCS) by reducing triglyceride levels in the blood.
-
E.
velpatasvir
Velpatasvir is a direct-acting antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C virus infection across multiple genotypes.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.